Multi-System Reach Beyond the gut, BPC-157 has preclinical evidence across tendons, ligaments, muscles, bone, the liver, and the nervous system
Only a physician can determine whether a specific product is correct for a particular patient
Perceived benefits of treatment for obesity with retatrutide: A qualitative study of patients in a phase 2 clinical trial
Audio transcript NINA MOINI: The amount of weight loss drugs on the market is about to shrink dramatically and cut thousands of Americans off from cheaper obesity drugs as the FDA halts the sale of these copycats
You should discard an opened vial of bacteriostatic water 28 days after it is first punctured, regardless of the remaining volume
The peptide's effects on both dopamine and serotonin systems suggest broad neuromodulatory activity beyond simple tissue healing